SCHEMBL29960907

SCHEMBL29960907

C=C1CCOc2ncccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GMNN O75496 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MMP2 P08253 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
MMP9 P14780 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MMP8 P22894 1/20 0.34
CCR1 P32246 1/20 0.34
THPO P40225 1/20 0.34
MTOR P42345 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13845114 0.81 TDP1 (0.37) TDP1KDM4EGMNNLMNATP53
SCHEMBL1404621 0.78 GRM5 (0.48) TDP1NFKB1SMN1; SMN2P2RX7TDP2
SCHEMBL618831 0.72
SCHEMBL4070563 0.70 PIK3CA (0.37) TDP1LMNAHTTSMN1; SMN2TDP2
SCHEMBL13845088 0.68 CYP19A1 (0.36) TDP1KDM4EGMNNLMNATP53
SCHEMBL30667190 0.68 CYP19A1 (0.36) TDP1KDM4EGMNNLMNATP53
SCHEMBL5173946 0.68 ITGB2 (0.48) LMNATSHRHTTSMN1; SMN2MEN1
SCHEMBL10370596 0.68 GRM5 (0.33) ACHETDP1KDM4EGMNNLMNA
SCHEMBL3063384 0.68 FABP6 (0.44) TDP1SMN1; SMN2TDP2NSD2ABL1
SCHEMBL31627399 0.66 AKT1 (0.33) ACHEPDE1APDE1BPDE1CPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed